[조사자료] 세계의 차세대 시퀀싱 (NGS) 서비스 시장 2024-2030 : 서비스 유형별 (인간 게놈 시퀀싱, 유전자 제어 서비스), 워크플로우별, 최종 용도별, 지역별

■ 영문 제목 : Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN049 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 150 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 차세대 시퀀싱 (NGS) 서비스 시장의 성장과 동향
Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 차세대 시퀀싱 서비스 시장 규모는 2030년까지 244억 8천만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 22.68%의 CAGR을 기록할 것으로 전망됩니다. 차세대 시퀀싱 (NGS) 기술의 개발은 재현성과 비용 절감 측면에서 유전자 시퀀싱에 혁명을 일으켰습니다. 그 결과, 임상 실험실과 병원에서의 사용을 촉진하기 위해 NGS 기술에 몇 가지 발전이 도입되었습니다. 현재 이 분야의 대부분의 혁신은 시퀀싱 기술의 사용법을 단순화하고 보다 정교하게 만드는 데 초점을 맞추고 있습니다. 이러한 요인들로 인해 다양한 최종 사용자들이 NGS 서비스를 이용하고 있습니다.

차세대 시퀀서는 지난 5년 동안 연구용에서 임상용으로 발전했습니다. 약 14개국이 대규모 유전체 시퀀싱 프로그램을 시작했으며, 2025년까지 약 6,000만 명이 유전체 분석을 받을 것으로 예상되고 있습니다. 전통적인 질병 검사 서비스 제공업체들은 시퀀싱 기반 유전자 검사의 증가 추세에 따라 포트폴리오를 확장하고 있습니다. 예를 들어, ARUP Laboratories는 2022년 3월에 새로운 코로나 바이러스 검사 출시를 발표했고, IDbyDNA, Inc.는 다른 회사와 협력하여 새로운 코로나 바이러스 검사, 호흡기 질환에 대한 NGS 검사를 도입하여 의사가 폐렴 및 기타 호흡기 질환 환자를 평가할 때 평가할 수 있도록 돕고 있습니다.

제약 및 생명공학 산업에서 하이스루풋 시퀀싱의 트렌드가 증가함에 따라, 하이스루풋 시퀀싱 플랫폼의 속도와 편의성을 개선하고 워크플로우를 단순화하기 위한 개발이 요구되고 있습니다. 이에 따라 각 업체들은 샘플의 증폭과 정제, 시작 입력을 간소화하는 솔루션 개발에 주력하고 있으며, 2022년 3월 일루미나는 TruSigh Oncology (TSO) Comprehensive (EU)의 출시를 발표했습니다. 이 제품은 여러 종양 유전자와 지표를 평가하여 환자의 암 개인의 분자 프로파일을 파악하는 종합적인 진단법입니다. 이 체외진단(IVD) 키트는 유럽 전역의 암 환자들의 유전체 결정에 영향을 미칠 수 있도록 도와주는 제품으로, 유럽에서 먼저 출시될 예정입니다.

차세대 시퀀싱 (NGS) 서비스 시장 보고서 하이라이트

- 서비스 유형별로는 전체 게놈 및 전체 엑솜 시퀀싱의 보급 확대로 2023년 인간 게놈 시퀀싱이 가장 큰 매출 점유율을 차지할 것으로 전망됩니다.

- 유전자 제어 서비스, 특히 소형 RNA 시퀀싱과 ChIP-seq는 예측 기간 동안 유리한 속도로 성장할 것으로 예상되며, RNA 시퀀싱에 대한 투자 증가로 유전자 제어 서비스의 성장을 촉진할 것으로 예상됩니다.

- 다른 워크플로우 단계에 비해 시퀀싱 서비스의 매출 비중이 높은 것은 시퀀싱 플랫폼 설치가 증가하고 있기 때문인 것으로 보입니다. 이 단계의 높은 유지 보수 및 회수 비용도 더 큰 수익을 창출하는 데 영향을 미치고 있습니다.

- 최종 용도별로는 대학 및 기타 연구기관이 2023년 가장 큰 매출 비중을 차지할 것으로 예상되는데, 이는 암 예후 및 진단에 NGS 기술의 적용이 확대되고 있고, 학술 기관 및 대학에서 주요 프로젝트를 진행하고 있기 때문으로 분석됩니다.

- 북미는 이 지역의 높은 기술 보급률과 기술 채택 및 질병 표적화를 위한 연구 성과 도출을 위한 자금 확보로 2023년 시장을 주도할 것으로 보입니다.

- 제네위즈(GENEWIZ), 노보젠(Novogene) 등의 기업들은 주요 NGS 개발 기업의 플랫폼을 기반으로 NGS 서비스를 제공하고 있습니다. 한편, 일루미나, BGI 등의 기업은 시퀀싱 장비 개발 및 연구기관에 서비스를 제공하고 있습니다.

- 2021년 11월 노보젠은 일본에서 열린 제44회 일본분자생물학회(MSBJ) 연례총회에서 일본 고객을 위해 특별히 단일세포 시퀀싱 서비스를 시작한다고 밝혔습니다.

- GENEWIZ의 과학자들은 프로젝트의 NGS 솔루션 식별을 지원하고 있으며, NeXT Dx Test는 Personalis, Inc.가 출시한 NeXT Dx Test는 암 전문의가 암 환자를 위한 새로운 치료법과 임상 시험 옵션을 식별하는 데 도움을 주고 있습니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 변수/동향/범위
4. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 서비스 유형별 비즈니스 분석
5. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 워크플로우별 비즈니스 분석
6. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 최종 용도별 비즈니스 분석
7. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 지역별 비즈니스 분석
8. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Decline in sequencing prices
3.3.2. Growing awareness pertaining to women & reproductive health
3.3.3. Strategies undertaken for implementation of clinical NGS
3.4. Market Restraint Analysis
3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
3.4.2. Analytical challenges in single cell sequencing
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Service Type Business Analysis
4.1. Global Next Generation Sequencing Services Market: Service Type Movement Analysis
4.2. Human Genome Sequencing Services
4.2.1. Human Genome Sequencing Services Market, 2018 – 2030 (USD Million)
4.3. Single-Cell Sequencing Services
4.3.1. Single-Cell Sequencing Services Market, 2018 – 2030 (USD Million)
4.4. Microbial Genome-based Sequencing Services
4.4.1. Microbial Genome-based Sequencing Services Market, 2018 – 2030 (USD Million)
4.5. Gene Regulation Services
4.5.1. Gene Regulation Services Market, 2018 – 2030 (USD Million)
4.5.2. Small RNA Sequencing Services
4.5.2.1. Small RNA Sequencing Services Market, 2018 – 2030 (USD Million)
4.5.3. Chip Sequencing Services
4.5.3.1. Chip Sequencing Services Market, 2018 – 2030 (USD Million)
4.5.4. Other Gene Regulation-based Service
4.5.4.1. Other Gene Regulation-based Service Market, 2018 – 2030 (USD Million)
4.6. Animal & Plant Sequencing Services
4.6.1. Animal & Plant Sequencing Services Market, 2018 – 2030 (USD Million)
4.7. Other Sequencing Services
4.7.1. Other Sequencing Services Market, 2018 – 2030 (USD Million)
Chapter 5. Workflow Business Analysis
5.1. Global Next Generation Sequencing Services market: Workflow Movement Analysis
5.2. Pre Sequencing Service
5.2.1. Pre Sequencing Service Market, 2018 – 2030 (USD Million)
5.3. Sequencing Service
5.3.1. Sequencing Service Market, 2018 – 2030 (USD Million)
5.4. Data Analysis Service
5.4.1. Data Analysis Service Market, 2018 – 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Global Next Generation Sequencing Services Market: End-use Movement Analysis
6.2. Universities & Other Research Entities
6.2.1. Universities & Other Research Entities Market, 2018 – 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market, 2018 – 2030 (USD Million)
6.4. Pharma & Biotech Entities
6.4.1. Pharma & Biotech Entities Market, 2018 – 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Next generation sequencing services market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Next generation sequencing services market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. Next generation sequencing services market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway Next generation sequencing services market, 2018 – 2030 (USD Million)
7.3.10. Switzerland
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Target Disease Prevalence
7.3.10.5. Switzerland Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand Next generation sequencing services market, 2018 – 2030 (USD Million)
7.4.8. Singapore
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Target Disease Prevalence
7.4.8.5. Singapore Next generation sequencing services market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Next generation sequencing services market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil Next generation sequencing services market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico Next generation sequencing services market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina Next generation sequencing services market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Next generation sequencing services market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa Next generation sequencing services market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE Next generation sequencing services market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait Next generation sequencing services market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market/Position Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Quest Diagnostics Incorporated
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. ARUP Laboratories
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Applied Biological Materials, Inc. (abm)
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Novogene Co, Ltd.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Azenta Life Sciences (GENEWIZ)
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. NanoString
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Illumina, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. PacBio
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Veritas
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. BGI (Beijing Genomics Institute)
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Gene by Gene Ltd.
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Lucigen Corporation
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 101 Participant’s Overview
Table 102 Financial Performance
Table 103 Key Companies Undergoing Expansions
Table 104 Key Companies Undergoing Acquisitions
Table 105 Key Companies Undergoing Collaborations
Table 106 Key Companies Launching New Products/Services
Table 107 Key Companies Undergoing Partnerships
Table 108 Key Companies Undertaking Other Strategies

※본 조사보고서 [세계의 차세대 시퀀싱 (NGS) 서비스 시장 2024-2030 : 서비스 유형별 (인간 게놈 시퀀싱, 유전자 제어 서비스), 워크플로우별, 최종 용도별, 지역별] (코드 : GRV24JAN049) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 차세대 시퀀싱 (NGS) 서비스 시장 2024-2030 : 서비스 유형별 (인간 게놈 시퀀싱, 유전자 제어 서비스), 워크플로우별, 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 차세대 시퀀싱 (NGS) 시장 2024-2030 : 기술별 (WGS, 타겟 시퀀싱, 리시퀀싱), 제품별 (플랫폼, 소모품), 용도별, 워크플로우별, 최종 용도별, 지역별
GRV24JAN048 / Grand View Research / 2023년 11월 / 글로벌 차세대 시퀀싱 (NGS) 시장의 성장 및 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 차세대 시퀀싱 (NGS) 시장 규모는 2024년부터 2030년까지 21.12%의 CAGR을 기록하며 2030년까지 312억 6천만 달러에...1. 조사 방법 및 범위 2. 개요 3. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 변수/동향/범위 4. 세계의 차세대 시퀀싱 (NGS) 시장 규모 :기술별 비즈니스 분석 5. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 제품별 비즈니스 분석 6. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 용도별 비즈니스 분석 7. 세계의...

세계의 차세대 시퀀싱 (NGS) 서비스 시장 2023-2030 : 유형별 (인간 게놈 시퀀싱, 단일 세포 시퀀싱, 미생물 게놈 기반 시퀀싱, 기타), 워크플로우별 (사전 시퀀싱, 시퀀싱, 데이터 분석), 최종 용도별 (대학 및 기타 연구 기관, 병원 및 클리닉, 기타), 지역별
BZW24FEB070 / Bizwit Research & Consulting / 2024年1月 / 세계의 차세대 시퀀싱 (NGS) 서비스 시장은 2022년 약 4.8억 달러로 평가되며, 예측 기간인 2023년부터 2030년까지 22.68% 이상의 견조한 성장률을 기록할 것으로 예상됩니다. 차세대 시퀀싱 (NGS) 서비스에는 전문 서비스 제공업체가 제공하는...1. 개요 2. 시장 정의 및 범위 3. 시장 동향 4. 산업 분석 5. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 유형별 6. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 워크플로우별 7. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 최종 용도별 8. 세계의 차세대 시퀀싱 (NGS) 서비스...

세계의 타겟 시퀀싱 및 리시퀀싱 시장 (2023~2030) : NGS, 기타
GRV23MR040 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 타겟 시퀀싱 및 리시퀀싱 시장 규모가 2023년부터 2030년 사이에 CAGR 22.59% 증가하여, 2030년에는 257억 달러에 달할 것으로 전망하고 있습니다. 본 조사...Targeted Sequencing And Resequencing Market Growth & Trends The global targeted sequencing and resequencing market size is expected to reach USD 25.7 billion expanding at a CAGR of 22.59% from 2023 to 2030, according to a new report by Grand View Research, Inc. Owing to the continuous technological developments in...

세계의 차세대 시퀀싱 (NGS) 서비스 시장 (2023~2030) : 인간 게놈 시퀀스, 유전자 제어 서비스
GRV23MR124 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모가 2023년부터 2030년 사이에 CAGR 22.56% 증가하여, 2030년에는 245억 달러에 달할 것으로 예측하고 있습니다. 본 조사...Next-generation Sequencing Services Market Growth & Trends The global next-generation sequencing services market size is expected to reach USD 24.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.56% from 2023 to 2030. The development of...

세계의 전게놈 시퀀스 (WGS) 시장 (2023~2030) : 기기, 소모품, 서비스
GRV23MR045 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 전게놈 시퀀스 (WGS) 시장 규모가 2023년부터 2030년 사이에 CAGR 20.06% 증가하여, 2030년에는 66.7억 달러에 달할 것으로 전망하고 있습니다. 본 자료는 세계의...Whole Genome Sequencing Market Growth & Trends The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 20.06% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to...